Summary

Description

<p> The ability to monitor microbial contamination remains a critical technique in the mitigation of risk to crew health and vehicle systems during human spaceflight missions. Current methods of bacterial and fungal monitoring on the International Space Station (ISS) depend on culturing of microorganisms during spaceflight and subsequent ground-based identification. This approach requires substantial crew time, uses consumables with short shelf lives, and prevents a rapid response to microbial contamination. To address these limitations for future missions beyond low-Earth orbit, a biosensor using gold nanoparticles is being developed for the rapid detection of medically significant microorganisms. For proof-of-concept, we have targeted the detection of Staphylococcus aureus, a common infectious agent that has been repeatedly isolated aboard the ISS. Gold nanoparticles were modified by the covalent attachment of an antibody that has a high binding affinity for a protein on the cell wall of S. aureus. Upon interaction with a sample containing S. aureus, binding between the nanoparticles and the bacteria occurred rapidly. A significant reduction in the red coloration of the colloidal nanoparticle suspension, and the formation of a large purple pellet was observed following a brief centrifugation step. Comparison of the absorbance spectra verified the visual observation, demonstrating that there was a significant reduction in the absorbance of the supernatants of reaction samples in which S. aureus was present. This biosensing system provides a rapid means to specifically detect only the targeted organism. Further development will potentially lead to a small, lightweight biosensor that can be easily adapted to detect other selected microorganisms in real-time, providing crews of future spaceflight missions a simple method to autonomously define potential infectious disease risks.</p>